As of November 12, 2026, MGM-15 (dihydro-7-hydroxymitragynine) is illegal to sell (federally scheduled; state law on file reads gray area) in Illinois. Federal Schedule I (DEA temporary order, drug code 9673), effective 2026-08-26 to 2028-08-26. Controlling source: 720 ILCS 570/201 Illinois Controlled Substances Act.
Verified November 12, 2026 (hash check) · confidence: under reviewIs MGM-15 Legal? Every state and federal law
Illinois MGM-15 ban status: ban in force
720 ILCS 570/201(d), as amended by P.A. 104-819 (eff. 2026-08-07), provides that when a substance is scheduled under federal law and notice is given, the Department of Human Services shall similarly control it after 30 days from Federal Register publication of a final order, and if the Department does not act within that period the substance is considered scheduled in the same manner as federal law unless the Department or an adversely affected party objects. The DEA order placing MGM-15 in Schedule I is a temporary scheduling order under 21 U.S.C. 811(h) published 2026-08-26; whether a temporary order is a 'final order' for 201(d), and whether any objection was filed, could not be confirmed from the record, so control in Illinois on or after 2026-09-25 is an interpretive question. Separately, the Kratom Control Act (720 ILCS 642/5) defines kratom to include any compound, derivative or preparation of Mitragyna speciosa, including 7-hydroxymitragynine, and bars sale to or possession by persons under 18; whether a semi-synthetic or synthetic derivative such as MGM-15 is a 'derivative ... of that plant' is also definitional. Checked: Schedule I (720 ILCS 570/204) does not name MGM-15, 7-hydroxymitragynine or mitragynine; no synthetic or semi-synthetic kratom ban is enacted (HB 4737 not enacted); SB 4202 (2026), which would further amend 201(d), is pending and does not set status; the controlled substance analog provisions reach only analogs of scheduled substances, and 7-hydroxymitragynine is not scheduled in Illinois; 720 ILCS 570/102(f-5)(2) also defines an analog by a substantially similar or greater effect than a Schedule I or II substance, a second interpretive route. Federal Schedule I (temporary, DEA-1644) applies regardless of this state row; the state row governs after the order lapses.
(d) If any substance is scheduled, rescheduled, or deleted as a controlled substance under Federal law and notice thereof is given to the Department, the Department shall similarly control the substance under this Act after the expiration of 30 days from publication in the Federal Register of a final order scheduling a substance as a controlled substance or rescheduling or deleting a substance. If the Department does not take action within 30 days, at the conclusion of the 30-day period the substance shall be considered scheduled, rescheduled, or deleted in the same manner as the federal law, unless within that 30-day period the Department objects
Among Illinois’s 5 neighbors, Indiana, Iowa, Kentucky, Missouri and Wisconsin are illegal, the same posture as Illinois.
Open the interactive map · Every compound in Illinois · Where MGM-15 is banned · Embed this map
Federally scheduled or prohibited. Federal Schedule I (DEA temporary order, drug code 9673), effective 2026-08-26 to 2028-08-26 Federal detail
3 instruments on file for this compound’s framework in Illinois; 4 of 4 citations above are official sources. Each text carries its source and a fingerprint that changes when the law does.
571e6da652da6623(720 ILCS 570/201) (from Ch. 56 1/2, par. 1201) Sec. 201. (a) The Department shall carry out the provisions of this Article. The Department or its successor agency may, by administrative rule, add additional substances to or delete or reschedule all controlled substances in the Schedules of Sections 204, 206, 208, 210 and 212 of this Act. In making a determination regarding the addition, deletion, or rescheduling of a substance, the Department shall consider the following: (1) the actual or relative potential for misuse; (2) the scientific evidence of its pharmacological effect, if known; (3) the state of current scientific knowledge regarding the substance; (4) the history and current pattern of misuse; (5) the scope, duration, and significance of misuse; (6) the risk to the public health; (7) the potential of the substance to produce psychological or physiological dependence or a substance use disorder; (8) whether the substance is an immediate precursor of a substance already controlled under this Article; (9) the immediate harmful effect in terms of potentially fatal dosage; and (10) the long-range effects in terms of permanent health impairment. (b) (Blank). (c) (Blank). (d) If any substance is scheduled, rescheduled, or deleted as a controlled substance under Federal law and notice thereof is given to the Department, the Department shall similarly control the substance under this Act after the expiration of 30 days from publication in the Federal Register of a final order scheduling a substance as a controlled substance or rescheduling or deleting a substance. If the Department does not take action within 30 days, at the conclusion of the 30-day period the substance shall be considered scheduled, rescheduled, or deleted in the same manner as the federal law, unless within that 30-day period the Department objects, or a party adversely affected files with the Department substantial written objections objecting to inclusion, rescheduling, or deletion. In that case, the Department shall publish the reasons for objection and afford all interested parties an opportunity to be heard in a public hearing to be held no later than 45 days after the statement of objection. After the public hearing, the Department shall publish its decision within 14 days of the conclusion of the public hearing, by means of a rule, which shall be final unless altered by statute. Upon publication of objections by the Department, similar control under this Act whether by inclusion, rescheduling or deletion is stayed until the Department publishes its ruling. (e) (Blank). (f) (Blank). (g) Authority to control under this Section does not extend to distilled spirits, wine, malt beverages, or tobacco as those terms are defined or used in the Liquor Control Act of 1934 and the Tobacco Products Tax Act of 1995. (h) Persons registered with the Drug Enforcement Administration to manufacture or distribute controlled substances shall maintain adequate security and provide effective controls and procedures to guard against theft and diversion, but shall not otherwise be required to meet the physical security control requirements (such as cage or vault) for Schedule V controlled substances containing pseudoephedrine or Schedule II controlled substances containing dextromethorphan. (Source: P.A. 103–881, eff. 1-1-25; 104-819, eff. 8-7-26.)
85c3197e563d65d2(720 ILCS 642/1) Sec. 1. This Act may be cited as the Kratom Control Act. (720 ILCS 642/5) Sec. 5. (a) As used in this Act, "Kratom" means any parts of the plant Mitragyna speciosa, whether growing or not, and any compound, manufacture, salt, derivative, mixture, or preparation of that plant, including but not limited to mitragynine and 7-hydroxymitragynine. (b) A minor under 18 years of age shall not knowingly purchase or possess any product containing any quantity of Kratom. (c) [no false ID]. (d) A person shall not knowingly sell, buy for, distribute samples of, or furnish any product containing any quantity of Kratom to any minor under 18 years of age. (e) Sentence. Violation of (b) or (c) is a Class B misdemeanor. Violation of (d) is a Class B misdemeanor for which the offender shall be fined not less than $500.
7d1ba7675fdc14e2(720 ILCS 642/5) Sec. 5. Kratom sale to or possession by minors prohibited. (a) As used in this Act, "Kratom" means any parts of the plant Mitragyna speciosa, whether growing or not, and any compound, manufacture, salt, derivative, mixture, or preparation of that plant, including but not limited to mitragynine and 7-hydroxymitragynine. (b) A minor under 18 years of age shall not knowingly purchase or possess any product containing any quantity of Kratom. (c) A minor under 18 years of age in the furtherance or facilitation of obtaining any product containing Kratom shall not knowingly display or use a false or forged identification card or transfer, alter, or deface an identification card. (d) A person shall not knowingly sell, buy for, distribute samples of, or furnish any product containing any quantity of Kratom to any minor under 18 years of age. (e) Sentence. Violation of subsection (b) or (c) of this Section is a Class B misdemeanor. Violation of subsection (d) of this Section is a Class B misdemeanor for which the offender shall be fined an amount of not less than $500. (Source: P.A. 98-981, eff. 1-1-15.)
Compound Laws, published by Compound Analytics, reports the record: statutes verbatim, official citations, enforcement facts and verification dates. Nothing here is legal advice and nothing here describes how to get around a law. A jurisdiction with no verified row is reported as not yet verified, never as legal. Found an error? Corrections policy.
About · Methodology · Glossary · Changes · RSS · Data licensing · llms.txt · Sitemap